KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Change in Receivables (2016 - 2025)

LifeMD filings provide 14 years of Change in Receivables readings, the most recent being $459227.0 for Q4 2025.

On a quarterly basis, Change in Receivables rose 162.48% to $459227.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 125.64% decrease, with the full-year FY2025 number at -$1.2 million, down 125.64% from a year prior.
Change in Receivables hit $459227.0 in Q4 2025 for LifeMD, up from -$95817.0 in the prior quarter.
In the past five years, Change in Receivables ranged from a high of $4.8 million in Q3 2024 to a low of -$1.5 million in Q1 2025.
Median Change in Receivables over the past 5 years was $356301.5 (2021), compared with a mean of $397734.8.
Biggest five-year swings in Change in Receivables: soared 2962.51% in 2023 and later crashed 2644.03% in 2025.
LifeMD's Change in Receivables stood at -$986755.0 in 2021, then surged by 164.33% to $634825.0 in 2022, then skyrocketed by 35.26% to $858668.0 in 2023, then tumbled by 185.6% to -$734988.0 in 2024, then skyrocketed by 162.48% to $459227.0 in 2025.
The last three reported values for Change in Receivables were $459227.0 (Q4 2025), -$95817.0 (Q3 2025), and -$6840.0 (Q2 2025) per Business Quant data.